Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

143 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Inflammatory bowel disease patient-reported quality assessment should drive service improvement: a national survey of UK IBD units and patients.
Hawthorne AB, Glatter J, Blackwell J, Ainley R, Arnott I, Barrett KJ, Bell G, Brookes MJ, Fletcher M, Muhammed R, Nevill AM, Segal J, Selinger CP, St Clair Jones A, Younge L; IBD UK Board IBD UK Task & Finish Group; Lamb CA. Hawthorne AB, et al. Among authors: arnott i. Aliment Pharmacol Ther. 2022 Aug;56(4):625-645. doi: 10.1111/apt.17042. Epub 2022 Jun 1. Aliment Pharmacol Ther. 2022. PMID: 35770866 Free PMC article.
Genome-Wide Methylation Profiling in 229 Patients With Crohn's Disease Requiring Intestinal Resection: Epigenetic Analysis of the Trial of Prevention of Post-operative Crohn's Disease (TOPPIC).
Ventham NT, Kennedy NA, Kalla R, Adams AT, Noble A, Ennis H; TOPPIC Study Group; IBD-BIOM Consortium; Mowat C, Dunlop MG, Satsangi J. Ventham NT, et al. Cell Mol Gastroenterol Hepatol. 2023;16(3):431-450. doi: 10.1016/j.jcmgh.2023.06.001. Epub 2023 Jun 17. Cell Mol Gastroenterol Hepatol. 2023. PMID: 37331566 Free PMC article. Clinical Trial.
The use of adalimumab in the management of refractory Crohn's disease.
Ho GT, Smith L, Aitken S, Lee HM, Ting T, Fennell J, Lees CW, Palmer KR, Penman ID, Shand AG, Arnott ID, Satsangi J. Ho GT, et al. Among authors: arnott id. Aliment Pharmacol Ther. 2008 Feb 15;27(4):308-15. doi: 10.1111/j.1365-2036.2007.03583.x. Epub 2007 Dec 7. Aliment Pharmacol Ther. 2008. PMID: 18081730 Free article. Clinical Trial.
The safety profile of anti-tumour necrosis factor therapy in inflammatory bowel disease in clinical practice: analysis of 620 patient-years follow-up.
Lees CW, Ali AI, Thompson AI, Ho GT, Forsythe RO, Marquez L, Cochrane CJ, Aitken S, Fennell J, Rogers P, Shand AG, Penman ID, Palmer KR, Wilson DC, Arnott ID, Satsangi J. Lees CW, et al. Among authors: arnott id. Aliment Pharmacol Ther. 2009 Feb 1;29(3):286-97. doi: 10.1111/j.1365-2036.2008.03882.x. Aliment Pharmacol Ther. 2009. PMID: 19132970 Free article.
143 results